To Örebro University

oru.seÖrebro University Publications
EnglishSvenskaNorsk
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
HER4 tumor expression in breast cancer patients randomized to treatment with or without tamoxifen
Örebro University, School of Health and Medical Sciences, Örebro University, Sweden.ORCID iD: 0000-0002-7498-7157
Örebro University Hospital.
Linköping University Hospital.
Linköping University.
Show others and affiliations
(English)Manuscript (preprint) (Other (popular science, discussion, etc.))
Keywords [en]
Breast cancer, ErbB4, HER4, randomized patients, tamoxifen
National Category
Cancer and Oncology
Research subject
Biomedicine
Identifiers
URN: urn:nbn:se:oru:diva-44646OAI: oai:DiVA.org:oru-44646DiVA, id: diva2:812376
Available from: 2015-05-18 Created: 2015-05-18 Last updated: 2017-10-17Bibliographically approved
In thesis
1. Biological profiles of endocrine breast cancer
Open this publication in new window or tab >>Biological profiles of endocrine breast cancer
2015 (English)Doctoral thesis, comprehensive summary (Other academic)
Place, publisher, year, edition, pages
Örebro: Örebro university, 2015. p. 82
Series
Örebro Studies in Medicine, ISSN 1652-4063 ; 123
Keywords
Endocrine breast cancer, tamoxifen, Foxl2, Wwox, ErbB4, HER4, gene expression, randomized patients
National Category
Cancer and Oncology
Research subject
Biomedicine
Identifiers
urn:nbn:se:oru:diva-43963 (URN)978-91-7529-071-3 (ISBN)
Public defence
2015-05-29, Universitetssjukhuset, Wilandersalen, Södra Grev Rosengatan, Örebro, 09:00 (Swedish)
Opponent
Supervisors
Funder
Swedish Cancer SocietyCancer and Allergy Foundation
Note

Funding: Magnus Bergvall Cancer Foundation; Percy Falk foundation for research in breast and prostate cancer; Nyckelfonden; Örebro University Hospital; Lions cancer research foundation, Region Uppsala-Örebro

Available from: 2015-03-30 Created: 2015-03-30 Last updated: 2017-10-17Bibliographically approved

Open Access in DiVA

No full text in DiVA

Authority records

Göthlin Eremo, AnnaFransén, KarinWingren, Sten

Search in DiVA

By author/editor
Göthlin Eremo, AnnaFransén, KarinWingren, Sten
By organisation
School of Health and Medical Sciences, Örebro University, SwedenSchool of Medicine, Örebro University, Sweden
Cancer and Oncology

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 723 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
v. 2.40.0
|
WCAG
|
Örebro University Library
|
DiVA Portal
|
DiVA Log in
|
Register in DiVA
|
Contact us